Growth Metrics

Palvella Therapeutics (PVLA) Cash & Equivalents Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -68.22%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 988.88%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 15.64%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.77%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.50%
7 Evaxion A 62.56 Bn 62.54 Bn - 3.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -4.13%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 67.78%
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - 172.91%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 172.91%
Dec 31, 2025 -30.65%
Sep 30, 2025 347.43%
Jun 30, 2025 384.51%
Mar 31, 2025 1,110.40%
Dec 31, 2024 1,037.44%
Sep 30, 2024 -68.29%
Jun 30, 2024 -73.52%
Mar 31, 2024 -84.28%
Dec 31, 2023 -80.98%
Sep 30, 2023 -7.48%
Jun 30, 2023 1.19%
Mar 31, 2023 -52.54%
Dec 31, 2022 -67.19%
Sep 30, 2022 38.75%
Jun 30, 2022 -40.90%
Mar 31, 2022 25.29%
Dec 31, 2021 67.19%
Sep 30, 2021 -47.82%
Jun 30, 2021 107.21%
Mar 31, 2021 40.91%
Dec 31, 2020 13.13%
Sep 30, 2020 45.20%
Jun 30, 2020 -19.31%
Mar 31, 2020 -8.95%
Dec 31, 2019 -13.46%
Sep 30, 2019 -48.52%
Jun 30, 2019 8.55%
Mar 31, 2019 -52.43%
Dec 31, 2018 89.93%
Sep 30, 2018 -0.49%
Jun 30, 2018 0.50%
Mar 31, 2018 98.26%
Dec 31, 2017 29.03%
Sep 30, 2017 145.97%
Jun 30, 2017 24.64%
Mar 31, 2017 77.12%
Dec 31, 2016 0.02%
Sep 30, 2016 13.34%
Jun 30, 2016 302.64%
Mar 31, 2016 136.87%
Dec 31, 2015 58.87%
Sep 30, 2015 3,345.36%
Jun 30, 2015 575.24%
Mar 31, 2015 302.68%
Dec 31, 2014 400.74%
Sep 30, 2014 135,973.11%
Jun 30, 2014 28,457.81%